Background And Aim: Polio eradication efforts including polio-philanthropy have been coordinated and sustained since 1988, with the introduction of the Global Polio Eradication Initiative (GPEI). The polio fight is sustained in the name of evidence-based benevolence or beneficent philanthropy from which Africa has benefited immensely. With the recorded polio cases as of 2023, more efforts and funds are required to eradicate polio. Hence, it is not yet "Uhuru." Using the Mertonian lens, this study examines polio-philanthropy in Africa, its unintended consequences, and crucial dilemmas, which could impact the polio fight and polio-philanthropy.

Methods: This is a narrative review that relies on secondary sources obtained through a thorough literature search. Only studies published in English were utilized. The study synthesized relevant literature in line with the study objective. The following databases were consulted: PubMed, philosopher's index, web of knowledge, Google Scholar, and Sociological Abstracts. Both empirical and theoretical studies were utilized for the study.

Results: Despite significant achievements, the global initiative has shortcomings when examined through the Mertonian lens of manifest and latent functions. The GPEI sets a unilinear goal within multiple challenges. The activities of the philanthropic giants manifest in disempowering rigor, multisectoral neglect, and parallel (health) systems, sometimes, inimical to the national health system. Most philanthropic giants often operate vertically. It is observed that, apart from funding, the last phase of polio-philanthropy will be defined by some crucial factors, the 4Cs: Communicable disease outbreaks, Conflict, Climate-related disasters, and Conspiracy theory, which could impact the prevalence or resurgence of polio.

Conclusion: The polio fight will benefit from the persistent drive to reach the finish line as scheduled. The latent consequences or dysfunctions are general lessons for GPEI and other global health initiatives. Therefore, decision-makers should calculate the net balance of consequences within global health philanthropy for appropriate mitigation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265140PMC
http://dx.doi.org/10.1002/hsr2.1339DOI Listing

Publication Analysis

Top Keywords

polio fight
12
polio-philanthropy africa
8
narrative review
8
polio eradication
8
mertonian lens
8
philanthropic giants
8
global health
8
polio
7
polio-philanthropy
4
africa narrative
4

Similar Publications

Jonas Salk (1914-1995): Pioneering the Fight Against Polio and Beyond.

Cureus

September 2024

Department of Community Medicine, Jawaharlal Nehru Medical College, School of Epidemiology and Public Health, Datta Meghe Institute of Higher Education & Research, Wardha, IND.

Jonas Salk (October 28, 1914 - June 23, 1995) was an American medical researcher celebrated for his pioneering work in virology, particularly the development of the first successful polio vaccine. This review highlights Salk's multifaceted talent and contributions. His research on the poliovirus led to the creation of the inactivated polio vaccine, proving that it could prevent the disease.

View Article and Find Full Text PDF
Article Synopsis
  • * A survey conducted in African Union Member States revealed significant variability in testing capacity and diagnostic technologies across countries, with many nations struggling to address challenges related to priority diseases like dengue and Crimean-Congo haemorrhagic fever.
  • * Investments in diagnostic capacity for diseases like COVID-19, polio, and measles showed better outcomes, but the lack of multiplex testing and overall limited laboratory capabilities raised concerns about preparedness for future outbreaks.
View Article and Find Full Text PDF
Article Synopsis
  • * Virus-like particle (VLP) and nanoparticle (NP) vaccines are innovative approaches that utilize self-assembling viral proteins or nanomaterials to present viral antigens and provoke strong immune responses.
  • * The review discusses advancements in VLP and NP vaccine development against various picornaviruses, emphasizing the need for ongoing research to improve their effectiveness, stability, and interaction with the immune system.
View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted in the Dominican Republic to evaluate the safety and immune response of the trivalent oral polio vaccine (tOPV) in healthy children and infants in the context of developing new oral polio vaccines.
  • No serious adverse reactions were reported, and significant improvements in seroconversion (SC) and seroprotection (SP) rates were observed in both groups after vaccination.
  • These findings provide a reference point to compare the safety and effectiveness of new monovalent or trivalent oral polio vaccine formulations currently in development.
View Article and Find Full Text PDF
Article Synopsis
  • * The multi-target directed ligand (MTDL) strategy is proposed as a new approach to develop effective antiviral drugs by synthesizing compounds that can target multiple pathways of the virus.
  • * This study reviews previous clinical trials to identify promising antiviral candidates, suggesting that using MTDL could enhance drug efficacy, broaden treatment options, and potentially reduce side effects and the risk of drug resistance.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!